China: International Law

Cross-border litigation presents unique challenges when serving process on foreign defendants, particularly for Chinese companies facing U.S. federal or Unified Patent Court proceedings. Understanding the fundamental differences between common law and civil law approaches to service, along with the requirements of the Hague Service Convention, is essential for protecting procedural rights and ensuring the enforceability of judgments.

优先权制度为专利申请人提供了关键的时间保护，但在生物医药领域，如何平衡抢占申请时间与完善技术方案成为核心挑战。本文通过对比中国、

The European Union's trademark system has developed a sophisticated framework for identifying and regulating malicious trademark applications, with 'bad faith' serving...

China has rapidly emerged as a dominant force in early-stage biotech innovation, challenging traditional U.S. hubs like San Francisco and Boston through faster development timelines, lower clinical trial costs, and aggressive government support. As deal volume between Western biopharma companies and Chinese biotechs surges dramatically, industry leaders must navigate the complex balance between accessing China's growing scientific contributions and managing heightened geopolitical tensions and U.S. regulato

珠海市で開始されたマカオのイノベーション主体向け特許早期予備審査サービスにより、条件を満たすマカオの出願者は珠海の出願者と同等の

北京市が2026年中国国際サービス貿易交易会で発表した新ガイドラインは、国内特許予備審査と海外特許審査ハイウェイを組み合わせた迅速な審

The European Commission's practice of fully deducting anti-subsidy duties from anti-dumping duties faces a challenge as EU tire industry representatives seek to impose both measures cumulatively on Chinese imports.

Chinese AI models have entered the global first tier in technical capabilities, with API pricing significantly lower than overseas products. Combined with domestic electricity cost advantages...

China's new immigration regulation introduces a significant provision allowing exit bans on Chinese citizens who violate export control or technology transfer rules that may endanger national, industrial, or technological security. This development creates potential complications for multinational companies operating in technology-intensive industries, as Chinese employees, engineers, researchers, or executives could be barred from departing China without prior notice, affecting cross-border mobility, joint